Indeed, the absence of CXCR6 in the transplantable MC38 colon tumor model drastically reduced the response to immune checkpoint therapy and decreased the number and cytotoxic effector activity of tumor-infiltrating CD8+ T cells [25]. Here, CXCR6 is linked to neoplasm.